SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin disorders, announced ...

TD Cowen analyst Tyler Van Buren maintained a Buy rating on Arcutis Biotherapeutics (ARQT – Research Report) today and set a price target ...

The health of your gut might seem like a mystery, but it affects more than just your digestion. Surprising indicators like ...

The FDA has extended the review period for the sNDA for tapinarof cream, 1% in the treatment of atopic dermatitis.

A diagnosis of POD should be considered with young female and pediatric patients who do not respond to treatment for presumed rosacea, seborrheic dermatitis, or acne vulgaris. The precise etiology ...

Goodwin is presenting a two-part publication series covering life sciences trends involving license deals, M&A, and financing for Greater China’s ...